Aditya Bardia, MD, MPH
Director, Breast Cancer Research
Harvard Medical School
Massachusetts General Hospital
Aditya Bardia, MD, MPH, has disclosed that he has received consultant/advisor/speaker fees from AstraZeneca, Daiichi Pharma, Foundation Medicine, Genentech, Gilead Sciences, Immunomedics, Lilly, Merck, Novartis, Pfizer, Phillips, Radius Health, and Sanofi and funds for research support from AstraZeneca, Daiichi Pharma, Genentech, Gilead Sciences, Immunomedics, Lilly, Merck, Novartis, Pfizer, Radius Health, and Sanofi.
Kayla Douglas, PharmD
Director of Pharmacy
Mississippi Center for Advanced Medicine
Kristi Kay Orbaugh, MSN, NP, AOCNP, has disclosed that she has been a speaker for AstraZeneca, Bristol-Myers Squibb, DSI, Gilead Sciences, Lilly, MorphoSys, Pfizer, Regeneron, and Sanofi.
Sara Hurvitz, MD
Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Sara Hurvitz, MD, FACP, has disclosed that she has received funds for research support from Ambrx, Amgen, Arvinas, AstraZeneca, Bayer, CytomX, Daiichi-Sankyo, Dignitana, Genentech/Roche, Gilead Sciences, GlaxoSmithKline, Immunomedics, Lilly, MacroGenics, Novartis, OBI Pharma, Orinove, Pfizer, Phoenix Molecular Designs, Pieris, PUMA, Radius, Sanofi, Seattle Genetics/Seagen, and Zymeworks.
Danielle Roman, PharmD, BCOP
Manager, Clinical Pharmacy Services
Allegheny Health Network
Danielle Roman, PharmD, BCOP, has no relevant conflicts of interest to report.